CoBX BIO Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $19M

  • Investors
  • 11

CoBX BIO General Information

Description

Operator of a drug discovery platform intended to develop next-generation covalent therapies. The company's platform utilizes chemical proteomics, molecular modeling, and artificial intelligence to develop covalent inhibitors and molecular adhesive degraders, enabling pharmaceutical firms to address drug resistance and enhance therapeutic effectiveness through targeted protein removal.

Contact Information

Website
www.cobxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17th Floor, 88, Gasan digital 1-ro
  • Geumcheon-gu, Gasan-dong, IT Premier Tower
  • Seoul, 08590
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 17th Floor, 88, Gasan digital 1-ro
  • Geumcheon-gu, Gasan-dong, IT Premier Tower
  • Seoul, 08590
  • South Korea

CoBX BIO Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoBX BIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 01-Jul-2026 $19M Completed Generating Revenue
1. Seed Round 03-Jun-2025 Completed Generating Revenue
To view CoBX BIO’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CoBX BIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoBX BIO Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atinum Investment Venture Capital Minority
K2 Investment Partners Venture Capital Minority
Kiwoom Investment Venture Capital Minority
Company K Partners Venture Capital Minority
Forest Partners (Korea) Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

CoBX BIO FAQs

  • When was CoBX BIO founded?

    CoBX BIO was founded in 2024.

  • Where is CoBX BIO headquartered?

    CoBX BIO is headquartered in Seoul, South Korea.

  • What is the size of CoBX BIO?

    CoBX BIO has 25 total employees.

  • What industry is CoBX BIO in?

    CoBX BIO’s primary industry is Drug Discovery.

  • Is CoBX BIO a private or public company?

    CoBX BIO is a Private company.

  • What is CoBX BIO’s current revenue?

    The current revenue for CoBX BIO is .

  • How much funding has CoBX BIO raised over time?

    CoBX BIO has raised $24.5M.

  • Who are CoBX BIO’s investors?

    Atinum Investment, K2 Investment Partners, Kiwoom Investment, Company K Partners, and Forest Partners (Korea) are 5 of 11 investors who have invested in CoBX BIO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process